• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

界定接受辅助生殖技术的低预后患者:POSEIDON标准——原因

Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The Why.

作者信息

Esteves Sandro C, Roque Matheus, Bedoschi Giuliano M, Conforti Alessandro, Humaidan Peter, Alviggi Carlo

机构信息

ANDROFERT, Andrology and Human Reproduction Clinic, Campinas, Brazil.

Department of Surgery, University of Campinas (UNICAMP), Campinas, Brazil.

出版信息

Front Endocrinol (Lausanne). 2018 Aug 17;9:461. doi: 10.3389/fendo.2018.00461. eCollection 2018.

DOI:10.3389/fendo.2018.00461
PMID:30174650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6107695/
Abstract

Women with impaired ovarian reserve or poor ovarian response (POR) to exogenous gonadotropin stimulation present a challenge for reproductive specialists. The primary reasons relate to the still limited knowledge about the POR pathophysiology and the lack of practical solutions for the management of these conditions. Indeed, clinical trials using the current standards to define POR failed to show evidence in favor of a particular treatment modality. Furthermore, critical factors for reproductive success, such as the age-dependent embryo aneuploidy rates and the intrinsic ovarian resistance to gonadotropin stimulation, are not taken into consideration by the current POR criteria. As a result, the accepted definitions for POR have been criticized for their inadequacy concerning the proper patient characterization and for not providing clinicians a guide for therapeutic management. A novel system to classify infertility patients with "expected" or "unexpected" inappropriate ovarian response to exogenous gonadotropins-the POSEIDON criteria-was developed to provide a more nuanced picture of POR and to guide physicians in the management of such patients. The new standards are provoking as they challenge the current terminology of POR in favor of the newly defined concept of "low prognosis." This article provides readers a critical appraisal of the existing criteria that standardize the definition of POR and explains the primary reasons for the development of the POSEIDON criteria.

摘要

卵巢储备功能受损或对外源性促性腺激素刺激卵巢反应不良(POR)的女性给生殖专家带来了挑战。主要原因在于对POR病理生理学的了解仍然有限,以及缺乏针对这些情况的实际管理解决方案。事实上,使用当前标准定义POR的临床试验未能显示出支持特定治疗方式的证据。此外,当前的POR标准没有考虑到生殖成功的关键因素,如年龄相关的胚胎非整倍体率和卵巢对促性腺激素刺激的内在抵抗。因此,公认的POR定义因其在正确描述患者特征方面的不足以及未为临床医生提供治疗管理指南而受到批评。一种用于将对促性腺激素有“预期”或“意外”不适当卵巢反应的不孕症患者进行分类的新系统——POSEIDON标准——被开发出来,以更细致地描述POR,并指导医生管理此类患者。新的标准引发了争议,因为它们挑战了当前POR的术语,转而支持新定义的“低预后”概念。本文为读者提供了对现有标准化POR定义标准的批判性评估,并解释了POSEIDON标准制定的主要原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b8c/6107695/afc1be3c77d9/fendo-09-00461-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b8c/6107695/afc1be3c77d9/fendo-09-00461-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b8c/6107695/afc1be3c77d9/fendo-09-00461-g0001.jpg

相似文献

1
Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The Why.界定接受辅助生殖技术的低预后患者:POSEIDON标准——原因
Front Endocrinol (Lausanne). 2018 Aug 17;9:461. doi: 10.3389/fendo.2018.00461. eCollection 2018.
2
The novel POSEIDON stratification of 'Low prognosis patients in Assisted Reproductive Technology' and its proposed marker of successful outcome.辅助生殖技术中“低预后患者”的新型波塞冬分层及其成功结局的提议标志物。
F1000Res. 2016 Dec 23;5:2911. doi: 10.12688/f1000research.10382.1. eCollection 2016.
3
Novel approaches for diagnosis and management of low prognosis patients in assisted reproductive technology: the POSEIDON concept.用于辅助生殖技术中低预后患者的诊断和管理的新方法:POSEIDON 概念。
Panminerva Med. 2019 Mar;61(1):24-29. doi: 10.23736/S0031-0808.18.03511-5. Epub 2018 Jul 18.
4
The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists.从临床医生和胚胎学家的视角看POSEIDON标准及其成功衡量指标
Front Endocrinol (Lausanne). 2019 Nov 20;10:814. doi: 10.3389/fendo.2019.00814. eCollection 2019.
5
Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept.体外受精中卵巢低反应管理的最新进展:从博洛尼亚标准到波塞冬概念的转变
Ther Adv Reprod Health. 2020 Jul 31;14:2633494120941480. doi: 10.1177/2633494120941480. eCollection 2020 Jan-Dec.
6
Ovarian Reserve Markers to Identify Poor Responders in the Context of Poseidon Classification.在波塞冬分类背景下用于识别低反应者的卵巢储备标志物
Front Endocrinol (Lausanne). 2019 May 8;10:281. doi: 10.3389/fendo.2019.00281. eCollection 2019.
7
Low Prognosis by the POSEIDON Criteria in Women Undergoing Assisted Reproductive Technology: A Multicenter and Multinational Prevalence Study of Over 13,000 Patients.POSEIDON 标准预测行辅助生殖技术的女性预后不良:一项超过 13000 例患者的多中心、多国患病率研究。
Front Endocrinol (Lausanne). 2021 Mar 12;12:630550. doi: 10.3389/fendo.2021.630550. eCollection 2021.
8
Androgens Profile in Blood Serum and Follicular Fluid of Women With Poor Ovarian Response During Controlled Ovarian Stimulation Reveals Differences Amongst POSEIDON Stratification Groups: A Pilot Study.控制性卵巢刺激过程中卵巢反应不良女性血清和卵泡液中的雄激素谱揭示了波塞冬分层组之间的差异:一项初步研究。
Front Endocrinol (Lausanne). 2019 Jul 16;10:458. doi: 10.3389/fendo.2019.00458. eCollection 2019.
9
Understanding Follicular Output Rate (FORT) and its Implications for POSEIDON Criteria.了解卵泡输出率(FORT)及其对波塞冬标准的影响。
Front Endocrinol (Lausanne). 2019 Apr 16;10:246. doi: 10.3389/fendo.2019.00246. eCollection 2019.
10
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria.ESHRE 共识:体外受精卵巢刺激反应不良的定义:博洛尼亚标准。
Hum Reprod. 2011 Jul;26(7):1616-24. doi: 10.1093/humrep/der092. Epub 2011 Apr 19.

引用本文的文献

1
Gonadotropin dose selection for repeat IVF cycles in POSEIDON Groups 1 and 2.波塞冬1组和2组重复体外受精周期的促性腺激素剂量选择
Front Endocrinol (Lausanne). 2025 Jul 17;16:1591743. doi: 10.3389/fendo.2025.1591743. eCollection 2025.
2
Ovarian Function Restoration Using Autologous Platelet-Rich Plasma.使用自体富血小板血浆恢复卵巢功能。
Reprod Med Biol. 2025 Jul 16;24(1):e12666. doi: 10.1002/rmb2.12666. eCollection 2025 Jan-Dec.
3
Effect of letrozole cotreatment in progestin-primed ovarian stimulation on IVF/ICSI outcomes in POSEIDON group 3 and 4 poor responders: a retrospective cohort study.

本文引用的文献

1
Estimation of age-dependent decrease in blastocyst euploidy by next generation sequencing: development of a novel prediction model.通过下一代测序估计胚胎囊胚非整倍体率随年龄的下降:一种新预测模型的建立。
Panminerva Med. 2019 Mar;61(1):3-10. doi: 10.23736/S0031-0808.18.03507-3. Epub 2018 Jun 28.
2
Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review.辅助生殖技术中重组促黄体生成素的补充:系统评价。
Fertil Steril. 2018 Apr;109(4):644-664. doi: 10.1016/j.fertnstert.2018.01.003.
3
Poor definition of poor-ovarian response results in misleading clinical recommendations.
来曲唑联合治疗在孕激素预处理的卵巢刺激中对波塞冬3组和4组低反应者体外受精/卵胞浆内单精子注射结局的影响:一项回顾性队列研究
Eur J Med Res. 2025 Apr 22;30(1):314. doi: 10.1186/s40001-025-02393-x.
4
Does the Timing of Antagonist Treatment Influence Cycle Outcomes in Unexpected Low Responders of POSEIDON Class 1 and 2?拮抗剂治疗时机是否会影响波塞冬1类和2类意外低反应者的周期结局?
J Clin Med. 2025 Mar 12;14(6):1901. doi: 10.3390/jcm14061901.
5
Acupuncture Increased the Number of Retrieved Oocytes in a Mouse Model of POR: The Involvement of DNA Methylation in the Oocytes.针刺增加了POR小鼠模型中回收的卵母细胞数量:DNA甲基化在卵母细胞中的作用。
Comb Chem High Throughput Screen. 2025;28(1):132-145. doi: 10.2174/0113862073264460231113052942.
6
Predicting factors of ovarian responses in infertile women with polycystic ovary syndrome undergoing IVF/ICSI.多囊卵巢综合征不孕女性接受体外受精/卵胞浆内单精子注射时卵巢反应的预测因素
J Assist Reprod Genet. 2025 Mar;42(3):865-874. doi: 10.1007/s10815-024-03386-1. Epub 2025 Jan 14.
7
The most appropriate indicators of successful ovarian stimulation.成功进行卵巢刺激的最恰当指标。
Reprod Biol Endocrinol. 2025 Jan 9;23(Suppl 1):5. doi: 10.1186/s12958-024-01331-6.
8
FSH/LH co-stimulation in Advanced Maternal Age (AMA) and hypo-responder patients - Arabian gulf delphi consensus group.高龄产妇(AMA)和低反应患者中的促卵泡生成素/促黄体生成素联合刺激——阿拉伯湾德尔菲共识小组
Front Endocrinol (Lausanne). 2024 Dec 12;15:1506332. doi: 10.3389/fendo.2024.1506332. eCollection 2024.
9
Astaxanthin improves assisted reproductive technology outcomes in poor ovarian responders through alleviating oxidative stress, inflammation, and apoptosis: a randomized clinical trial.虾青素通过减轻氧化应激、炎症和细胞凋亡改善卵巢反应不良患者的辅助生殖技术结局:一项随机临床试验。
J Ovarian Res. 2024 Oct 31;17(1):212. doi: 10.1186/s13048-024-01537-7.
10
From patient classification to optimized treatment in ART: the AMPLITUDE Delphi consensus.从患者分类到抗逆转录病毒治疗的优化:AMPLITUDE德尔菲共识。
Front Reprod Health. 2024 Sep 27;6:1467322. doi: 10.3389/frph.2024.1467322. eCollection 2024.
对卵巢反应不良的定义不明确会导致临床建议产生误导。
Hum Reprod. 2018 May 1;33(5):979-980. doi: 10.1093/humrep/dey059.
4
Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial.辅酶 Q10 预处理可改善卵巢储备功能降低的低预后年轻女性的卵巢反应和胚胎质量:一项随机对照试验。
Reprod Biol Endocrinol. 2018 Mar 27;16(1):29. doi: 10.1186/s12958-018-0343-0.
5
Individualized controlled ovarian stimulation in expected poor-responders: an update.个体化控制性卵巢刺激在预期卵巢低反应患者中的应用:更新。
Reprod Biol Endocrinol. 2018 Mar 9;16(1):20. doi: 10.1186/s12958-018-0342-1.
6
Poor ovarian response as a predictor for live birth in older women undergoing IVF.卵巢反应不良是预测高龄妇女接受试管婴儿治疗活产率的指标。
Reprod Biomed Online. 2018 Apr;36(4):435-441. doi: 10.1016/j.rbmo.2018.01.008. Epub 2018 Feb 3.
7
Role of Lh polymorphisms and r-hLh supplementation in GnRh agonist treated ART cycles: A cross sectional study.促黄体生成素(Lh)多态性及重组人促黄体生成素(r-hLh)补充在促性腺激素释放激素(GnRh)激动剂治疗的辅助生殖技术(ART)周期中的作用:一项横断面研究。
Eur J Obstet Gynecol Reprod Biol. 2018 Mar;222:119-125. doi: 10.1016/j.ejogrb.2018.01.025. Epub 2018 Feb 3.
8
Bologna criteria: clinically or academically relevant?博洛尼亚标准:与临床相关还是与学术相关?
Fertil Steril. 2018 Jan;109(1):59-60. doi: 10.1016/j.fertnstert.2017.10.022.
9
Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss in younger in vitro fertilization patients.通过基础促卵泡激素和窦卵泡计数测量的卵巢储备功能减退与年轻体外受精患者的流产无关。
Fertil Steril. 2017 Dec;108(6):980-987. doi: 10.1016/j.fertnstert.2017.09.011.
10
Utilization of the Bologna criteria: a promise unfulfilled? A review of published and unpublished/ongoing trials.博洛尼亚标准的应用:未兑现的承诺?已发表和未发表/正在进行的试验综述。
Fertil Steril. 2018 Jan;109(1):104-109.e2. doi: 10.1016/j.fertnstert.2017.09.024. Epub 2017 Nov 29.